[
  {
    "ts": "2026-02-17T05:33:18+00:00",
    "headline": "The Top 5 Analyst Questions From Zimmer Biomet’s Q4 Earnings Call",
    "summary": "Zimmer Biomet’s fourth quarter results were greeted positively by the market, with management crediting strong execution in the U.S. and robust demand for recently launched products as key drivers. CEO Ivan Tornos highlighted the impact of new product adoption, especially in knee and hip implants, and the effectiveness of direct-to-patient marketing campaigns. Tornos pointed to continued gains in robotics and navigation technologies, as well as double-digit growth in the company’s cranio-maxillo",
    "url": "https://finance.yahoo.com/news/top-5-analyst-questions-zimmer-053318081.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "7a62ae11-aa68-31b1-b10a-de3a15a0b26a",
      "content": {
        "id": "7a62ae11-aa68-31b1-b10a-de3a15a0b26a",
        "contentType": "STORY",
        "title": "The Top 5 Analyst Questions From Zimmer Biomet’s Q4 Earnings Call",
        "description": "",
        "summary": "Zimmer Biomet’s fourth quarter results were greeted positively by the market, with management crediting strong execution in the U.S. and robust demand for recently launched products as key drivers. CEO Ivan Tornos highlighted the impact of new product adoption, especially in knee and hip implants, and the effectiveness of direct-to-patient marketing campaigns. Tornos pointed to continued gains in robotics and navigation technologies, as well as double-digit growth in the company’s cranio-maxillo",
        "pubDate": "2026-02-17T05:33:18Z",
        "displayTime": "2026-02-17T05:33:18Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/6edde082034a9d932281221482f4ebed",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "ZBH Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GeR3T5vTqnjo7Gx.oPgKjw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/6edde082034a9d932281221482f4ebed.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QfijZY2TGZIuX4ND2T.vmw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/6edde082034a9d932281221482f4ebed.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-5-analyst-questions-zimmer-053318081.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-5-analyst-questions-zimmer-053318081.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ZBH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]